Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging.
E. Mark Haacke, Zachary DelProposto, Saurabh Chaturvedi, Vivek Sehgal, Morton J. Tenzer, Jaladhar Neelavalli, Daniel K. Kido
Abstract
E. Mark Haacke, Zachary DelProposto, Saurabh Chaturvedi, Vivek Sehgal, Morton J. Tenzer, Jaladhar Neelavalli, Daniel K. Kido
Abstract
Gradient-echo (GE) imaging is recognized as a means to detect hemorrhagic changes in cerebral amyloid angiopathy (CAA). However, almost 25% of patients with CAA do not show microhemorrhages on T2* GE imaging. We applied a new imaging method, susceptibility weighted imaging (SWI), to evaluate the presence of microhemorrhages. In a suspected case of CAA, where cognitive effects are also present, we show that SWI is much more sensitive in detecting microhemorrhages than conventional methods.
OpenAlex reports 135 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gradient-echo (GE) imaging is recognized as a means to detect hemorrhagic changes in cerebral amyloid angiopathy (CAA). However, almost 25% of patients with CAA do not show microhemorrhages on T2* GE imaging. We applied a new imaging method, susceptibility weighted imaging (SWI), to evaluate the presence of microhemorrhages. In a suspected case of CAA, where cognitive effects are also present, we show that SWI is much more sensitive in detecting microhemorrhages than conventional methods.
Key concepts: Susceptibility weighted imaging, Cerebral amyloid angiopathy, Medicine, Neuroimaging, Magnetic resonance imaging, Gradient echo, Quantitative susceptibility mapping, Pathology